330 related articles for article (PubMed ID: 19346102)
21. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
Feng Y
Hokkaido Igaku Zasshi; 1997 Jul; 72(4):443-55. PubMed ID: 9266252
[TBL] [Abstract][Full Text] [Related]
22. A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta.
Sharabi A; Zinger H; Zborowsky M; Sthoeger ZM; Mozes E
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8810-5. PubMed ID: 16735466
[TBL] [Abstract][Full Text] [Related]
23. A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.
Ben-David H; Sharabi A; Parameswaran R; Zinger H; Mozes E
Immunology; 2009 Oct; 128(2):245-52. PubMed ID: 19740381
[TBL] [Abstract][Full Text] [Related]
24. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Liu C; Chen X; Jin Y; Qu R; Jiang PF; Wen GM; Tang ZH
Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Li D; Song L; Fan Y; Li X; Li Y; Chen J; Zhu F; Guo C; Shi Y; Zhang L
Clin Immunol; 2009 Dec; 133(3):422-7. PubMed ID: 19748832
[TBL] [Abstract][Full Text] [Related]
26. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.
Barath S; Aleksza M; Tarr T; Sipka S; Szegedi G; Kiss E
Lupus; 2007; 16(7):489-96. PubMed ID: 17670847
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
[TBL] [Abstract][Full Text] [Related]
28. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity.
Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T
Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637
[TBL] [Abstract][Full Text] [Related]
29. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
30. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
32. The inhibition of autoreactive T cell functions by a peptide based on the CDR1 of an anti-DNA autoantibody is via TGF-beta-mediated suppression of LFA-1 and CD44 expression and function.
Sela U; Mauermann N; Hershkoviz R; Zinger H; Dayan M; Cahalon L; Liu JP; Mozes E; Lider O
J Immunol; 2005 Dec; 175(11):7255-63. PubMed ID: 16301630
[TBL] [Abstract][Full Text] [Related]
33. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Xu D; Roschke V; Wu Y; Baker KP; Hilbert DM
Arthritis Rheum; 2003 Dec; 48(12):3475-86. PubMed ID: 14673998
[TBL] [Abstract][Full Text] [Related]
34. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
[TBL] [Abstract][Full Text] [Related]
35. Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.
Sharabi A; Mozes E
Immunotherapy; 2009 May; 1(3):385-401. PubMed ID: 20635958
[TBL] [Abstract][Full Text] [Related]
36. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
Sharabi A; Mozes E
J Immunol; 2008 Sep; 181(5):3243-51. PubMed ID: 18713995
[TBL] [Abstract][Full Text] [Related]
37. Cryopreserved peripheral blood mononuclear cells are suitable for the assessment of immunological markers in type 1 diabetic children.
Axelsson S; Faresjö M; Hedman M; Ludvigsson J; Casas R
Cryobiology; 2008 Dec; 57(3):201-8. PubMed ID: 18761006
[TBL] [Abstract][Full Text] [Related]
38. Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus.
Valencia-Pacheco G; Layseca-Espinosa E; Niño-Moreno P; Portales-Pérez DP; Baranda L; Rosenstein Y; Abud-Mendoza C; González-Amaro R
Scand J Rheumatol; 2006; 35(5):368-78. PubMed ID: 17062437
[TBL] [Abstract][Full Text] [Related]
39. A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation.
Luger D; Dayan M; Zinger H; Liu JP; Mozes E
J Clin Immunol; 2004 Nov; 24(6):579-90. PubMed ID: 15622442
[TBL] [Abstract][Full Text] [Related]
40. The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients.
Langer S; Langnickel D; Enghard P; Undeutsch R; Burmester GR; Hiepe F; Radbruch A; Riemekasten G
Rheumatology (Oxford); 2007 Feb; 46(2):238-45. PubMed ID: 16880187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
